Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,705 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06138340Recruiting
How anesthesia affects brain networks in people with glioma
This study looks at how different anesthetics change brain connections during surgery for a type of brain tumor called glioma. It may help doctors choose the best anesthesia for your surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06139042Recruiting
Early detection of liver, bile duct, and pancreas cancers
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
Hangzhou, ZhejiangAges 40–75 - NCT06139692RecruitingPhase 4
Comparing light sedation during clot removal for stroke
This study compares two types of light sedation (medication to help you relax) during a procedure to remove a blood clot in the brain after a stroke. The goal is to find which sedation method helps patients recover better.
Nanjing, None SelectedAges 18 years+ - NCT06140589Recruiting
Cadonilimab for advanced cervical cancer
This trial tests a new immunotherapy drug called cadonilimab for women with cervical cancer that has returned, spread, or is advanced. The goal is to see if it works well, how safe it is, and if it costs less than standard treatments.
Fuzhou, FujianAges 18–80 - NCT06140966RecruitingPhase 2
Daratumumab and Carfilzomib combo for high-risk multiple myeloma
This trial tests a combination of the drugs daratumumab, carfilzomib, lenalidomide, and dexamethasone given before and after a stem cell transplant for people with ultra high-risk multiple myeloma. The goal is to see if this regimen is safe and more effective than standard treatments.
Wuhan, HubeiAges 18–70 - NCT06141226RecruitingPhase 2
New drug combo for immunotherapy-resistant lung cancer
This trial tests a combination of an immunotherapy drug (TQB2450), a targeted therapy (anlotinib), and chemotherapy for people with advanced non-small cell lung cancer whose cancer stopped responding to prior immunotherapy. It aims to find a new option when the first treatment didn't work anymore.
Huizhou, GuangdongAges 18–75 - NCT06141525Recruiting
Remote conditioning for safer heart bypass recovery
This study tests whether a simple, non-invasive treatment called remote ischemic conditioning (using a blood pressure cuff on your arm) can help patients recover better after off-pump heart bypass surgery. The goal is to see if it reduces complications and improves heart function.
Xi'an, ShaanxiAges 18–70 - NCT06142747Recruiting
Tracking blood flow in healthy and injured tendons
This study uses a special ultrasound to see how blood flows in tendons, comparing healthy people to those with overuse injuries. It may help doctors better understand and treat tendon problems.
CopenhagenAges 18–70 - NCT06143254Recruiting
Infant sign training for speech development
This trial tests whether teaching infants with cleft palate simple signs can help them communicate before they can speak. It may support their speech and language development.
Ghent, East FlandersAges 1–2 - NCT06143488Recruiting
Clot removal vs. best medicine for mild stroke with large vessel blockage
This trial tests whether removing a blood clot from a large brain artery is better than standard medical care for people who have a mild stroke (NIHSS score 2-5) but still have symptoms like trouble speaking, weakness, or confusion. It is for patients who can be treated within 24 hours of their last known well time.
Wuhu, AnhuiAges 18 years+ - NCT06143969Recruiting
Ultrasound-guided clot-dissolving treatment for intermediate-high risk pulmonary embolism
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
Milan, ItaliaAges 18 years+ - NCT06144021Recruiting
Kefir whey drink for muscle health in adults over 40
This study tests whether a fermented milk drink (kefir whey postbiotics) can help improve muscle mass in people over 40 who have low muscle. It is for generally healthy adults who are not taking certain medications or following special diets.
SeoulAges 40 years+ - NCT06144593Recruiting
Carb cutting for people with type 2 diabetes
This study looks at whether cutting carbs on certain days can improve metabolism for people with type 2 diabetes. It may help if you have mild to moderate diabetes and are overweight or obese.
HvidovreAges 35–75 - NCT06145074RecruitingPhase 2
Testing propranolol before surgery for pancreatic cancer
This trial tests if taking propranolol (a blood pressure medication) before surgery helps treat pancreatic cancer that can be removed. It aims to see if the drug is safe and works well.
CopenhagenAges 18 years+ - NCT06145828Recruiting
Testing a blood filter for severe pneumonia or sepsis in AIDS patients
This study tests a technique that filters harmful substances from the blood of people with AIDS who have severe pneumonia or septic shock. The goal is to see if this filter helps them recover better.
Guangzhou, GuangdongAges 18–65 - NCT06145711Recruiting
Stem cell therapy for Parkinson's disease
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
Shanghai, Shanghai MunicipalityAges 30–70 - NCT06145841Recruiting
Gene test to guide infection treatment in AIDS
This study is for people with HIV/AIDS who develop severe pneumonia or septic shock. It uses a special genetic test (metagenomic next-generation sequencing) to find the exact germ causing the infection so doctors can choose the right antibiotic.
Guangzhou, GuangdongAges 18–65 - NCT06145932Recruiting
Repetitive TMS for essential tremor
This trial tests whether repetitive transcranial magnetic stimulation (TMS) — a non-invasive treatment that uses magnetic pulses to calm overactive brain cells — can help reduce shaking in people with essential tremor. If you have essential tremor and no metal implants or other brain conditions, you may be eligible to participate.
SuzhouAges 18–80 - NCT06145906Recruiting
Optimizing catheter ablation for atrial fibrillation
This trial is studying a way to improve the entire process of catheter ablation for atrial fibrillation. It may help people who are having this procedure for the first time and have a normal-sized left atrium and good heart function.
Zhengzhou, HenanAges 18–80 - NCT06146010Recruiting
German leptomeningeal disease registry study
This study collects information from people with leptomeningeal disease, a condition where cancer spreads to the lining of the brain and spinal cord. By joining, you help researchers learn more about this disease and how it affects people.
BonnAges 18 years+ - NCT06146465Recruiting
Mobile apps for managing kids: what doctors think
This study asks doctors how they feel about using mobile health apps to care for children. Their answers may help improve child healthcare.
IzmirAges Any age - NCT06146751Recruiting
Improved MRI to detect blood clots in the heart
This trial tests a new type of MRI with a special dye (ferumoxytol) to better find blood clots in the heart. It is for people who have a left ventricular aneurysm (a bulging area in the heart's main pumping chamber) or who had a heart procedure called percutaneous ventricular reconstruction about 6 months ago.
Nanjing, JiangsuAges 18–80 - NCT06146764Recruiting
Better ultrasound for thyroid cancer diagnosis
This study uses a special ultrasound method called contrast-enhanced ultrasound (CEUS) to see if it can improve accuracy of diagnosing thyroid cancer. If you have a thyroid nodule and have had certain tests, this trial may help doctors better understand your condition.
Guangzhou, GuangdongAges 18 years+ - NCT06146790Recruiting
Endovascular treatment for strokes in smaller brain arteries
This trial tests a minimally invasive procedure to remove blood clots from smaller arteries deep inside the brain. It may help people with moderate to severe stroke symptoms who can be treated within 24 hours of symptom onset.
Hefei, AnhuiAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,705 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.